Status:
COMPLETED
Phase 4 Study - Mucinex D as Adjunct Therapy
Lead Sponsor:
Adams Respiratory Therapeutics
Conditions:
Acute Respiratory Infection
Bronchitis
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respirat...
Eligibility Criteria
Inclusion
- Ages Eligible for Study: 18 to 75 years,
- Genders Eligible for Study: Both
- Adult patients presenting at the physician's office with symptoms diagnostic for acute respiratory infection, such as bronchitis or rhinosinusitis; with a clinical diagnosis of acute respiratory infection, meeting the physician's usual diagnostic criteria in practice for prescription of oral antibiotics.
- The investigator will evaluate patients on a total of seven criteria for inclusion.
Exclusion
- Have chronic, recurring respiratory signs and symptoms, such as allergic rhinitis or chronic bronchitis, which, in the investigator's opinion, would confound interpretation of symptoms ratings for the acute respiratory infection;
- The Investigator will evaluate patients on twelve additional criteria for exclusion.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2007
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00441246
Start Date
February 1 2007
End Date
July 1 2007
Last Update
February 6 2008
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Alabama Clinical Therapuetics, LLC, 52 Medical Park East Drive, Suite 214
Birmingham, Alabama, United States, 35235
2
MedCenter, 6651 Madison Ave.
Carmichael, California, United States, 95608
3
Torrance Clinical Research, 3640 Lomita Blfd #205
Torrance, California, United States, 90505
4
Clinicos, LLC
Colorado Springs, Colorado, United States, 80904